Legal & General Group PLC Kymera Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 41,411 shares of KYMR stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,411

Previous 41,411 -0.0%

Holding current value

$1.75 Million

Previous $1.96 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.16 - $52.4 $218,931 - $380,371	-7,259 Reduced 14.91%	41,411 $1.96 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $184,622 - $243,812	6,185 Added 14.56%	48,670 $1.45 Million
Q1 2024 May 14, 2024	BUY	$22.9 - $43.57 $93,775 - $178,419	4,095 Added 10.67%	42,485 $1.71 Million
Q4 2023 Feb 15, 2024	BUY	$10.97 - $26.84 $80,980 - $198,132	7,382 Added 23.81%	38,390 $977,000
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $3,530 - $6,065	-254 Reduced 0.81%	31,008 $431,000
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $84,067 - $131,054	-3,753 Reduced 10.72%	31,262 $718,000
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $46,227 - $72,113	1,861 Added 5.61%	35,015 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $8,297 - $13,110	424 Added 1.3%	33,154 $827,000
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $84,204 - $138,005	4,027 Added 14.03%	32,730 $713,000
Q2 2022 Aug 22, 2022	BUY	$14.13 - $42.55 $3,645 - $10,977	258 Added 0.91%	28,703 $565,000
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $520,498 - $953,706	14,745 Added 107.63%	28,445 $1.2 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $15,222 - $19,995	305 Added 2.28%	13,700 $870,000
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $321,072 - $447,755	6,717 Added 100.58%	13,395 $787,000
Q2 2021 Aug 12, 2021	BUY	$31.08 - $51.95 $154,032 - $257,464	4,956 Added 287.8%	6,678 $324,000
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $855 - $2,051	-24 Reduced 1.37%	1,722 $67,000
Q4 2020 Feb 12, 2021	BUY	$28.07 - $87.83 $49,010 - $153,351	1,746 New	1,746 $109,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.31B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Kymera Therapeutics, Inc. Transaction History